A study performed by Fumagalli et al. [58] analyzed the genetic profiles of sufferers and looked at the impacts on metabolism. They particularly looked at human CHC22 clathrin, which plays a central job in intracellular targeted traffic of insulin-responsive glucose transporter 4 (GLUT4). The GLUT4